| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 2026-01-14 | 2,678 | $35.15 | $94.13kBuy |
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 2026-01-14 | 13,112 | $45.20 | $592.61kSell |
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 2026-01-14 | 1,407 | $18.08 | $25.44kBuy |
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 2026-01-14 | 321 | $7.62 | $2.45kBuy |
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 2026-01-14 | 2,813 | $10.00 | $28.13kBuy |
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 2026-01-14 | 5,893 | $15.75 | $92.81kBuy |
| Akshay Vaishnaw | President of RD | 2026-01-13 | 20,438 | $42.70 | $872.70kSell |
| David Hallal | Chief Executive Officer | 2026-01-13 | 57,450 | $42.70 | $2.45MSell |
| Vikas Sinha | Chief Financial Officer | 2026-01-13 | 16,755 | $42.70 | $715.44kSell |
| Keith Woods | Chief Operating Officer | 2026-01-13 | 16,746 | $42.70 | $715.05kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Srinivas Akkaraju | 16.49% | 16,820,422 | $782.65M | Insider |
| Fmr LLC | 13.74% | 14,012,078 | $651.98M | Institution |
| Siren LLC | 11.04% | 11,259,438 | $523.90M | Insider |
| Invus Public Equities LP | 9.07% | 9,250,005 | $430.40M | Insider |
| Siren LLC | 9.07% | 9,250,005 | $430.40M | Institution |
| Price T Rowe Associates Inc | 6.75% | 6,883,058 | $320.27M | Institution |
| Samsara Biocapital GP LLC | 6.66% | 6,788,609 | $315.87M | Insider |
| Blackrock Inc | 6.63% | 6,760,187 | $314.55M | Institution |
| Samsara Biocapital LLC | 5.50% | 5,612,896 | $261.17M | Institution |
| Kristina Burow | 4.91% | 5,004,399 | $232.85M | Insider |